Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED)
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
This is a 12-week clinical trial in lipid clinic patients for whom niacin therapy is
appropriate to evaluate the efficacy of MK0524 to improve the tolerability of
extended-release niacin. There will be 6 scheduled clinic visits and 3 treatment arms.